Press release
Prurigo Nodularis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Celgene Crp., Novartis, Pfizer, Galderma, Genentech, Incyte Crp., Trevi Therapeutics, Vyne Therap
DelveInsight's "Prurigo Nodularis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Prurigo Nodularis, historical and forecasted epidemiology as well as the Prurigo Nodularis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Prurigo Nodularis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Prurigo Nodularis Market Forecast [https://www.delveinsight.com/sample-request/prurigo-nodularis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Prurigo Nodularis Market Report:
*
The Prurigo Nodularis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In August 2024, Galderma has announced that the U.S. Food and Drug Administration (FDA) has approved Nemluvio Registered (nemolizumab) as a pre-filled pen for subcutaneous injection to treat adults with prurigo nodularis. Nemluvio received Breakthrough Therapy Designation in December 2019 and Priority Review in February 2024, highlighting its potential to significantly enhance treatment for serious conditions.
*
In March 2024, Incyte revealed recently released late-breaking data from a Phase II study assessing povorcitinib in individuals diagnosed with prurigo nodularis.
*
According to Morgan et al. (2022), the estimated prevalence of prurigo nodularis was recorded at 3.27 cases per 10,000 patients.
*
In 2023, among the 7MM, the United States had the largest diagnosed prevalent population of prurigo nodularis.
*
As per estimates, in Europe, the highest prevalence of age-specific cases of prurigo nodularis was observed in the 40-59 years age group, representing over 30% of the total cases in 2023.
*
DUPIXENT (dupilumab) stands as the sole therapeutic approved by the US FDA for the treatment of prurigo nodularis, with several other treatments currently undergoing development.
*
Key Prurigo Nodularis Companies: Trevi Therapeutics, Galderma, Genentech, Incyte Corporation, Vyne Therapeutics Inc., Celgene Corporation, Novartis, Pfizer, Regeneron Pharma, and others
*
Key Prurigo Nodularis Therapies: Nalbuphine ER, Nemolizumab, Vixarelimab(KPL-716), Povorcitinib(INCB-54707), Ruxolitinib Cream, INCB054707, serlopitant, CC-10004, Pimecrolimus, Abrocitinib, Dupilumab SAR231893, and others
*
The Prurigo Nodularis epidemiology based on gender analyzed that females are affected more as compared to males, in the case of Prurigo Nodularis
*
The Prurigo Nodularis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Prurigo Nodularis pipeline products will significantly revolutionize the Prurigo Nodularis market dynamics.
Prurigo Nodularis Overview
Prurigo nodularis is a chronic skin condition characterized by the development of intensely itchy nodules or bumps on the skin. These nodules can vary in size and color and often appear on the arms, legs, or trunk. The itching associated with prurigo nodularis can be severe and persistent, leading to scratching and potentially causing further irritation and skin damage. The exact cause of prurigo nodularis is not fully understood, but it is believed to involve a combination of factors such as underlying skin conditions, nerve dysfunction, and immune system abnormalities.
Get a Free sample for the Prurigo Nodularis Market Report
https://www.delveinsight.com/report-store/prurigo-nodularis-market [https://www.delveinsight.com/report-store/prurigo-nodularis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Prurigo Nodularis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Prurigo Nodularis Epidemiology Segmentation:
The Prurigo Nodularis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Prurigo Nodularis
*
Prevalent Cases of Prurigo Nodularis by severity
*
Gender-specific Prevalence of Prurigo Nodularis
*
Diagnosed Cases of Episodic and Chronic Prurigo Nodularis
Download the report to understand which factors are driving Prurigo Nodularis epidemiology trends @ Prurigo Nodularis Epidemiology Forecast [https://www.delveinsight.com/sample-request/prurigo-nodularis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Prurigo Nodularis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prurigo Nodularis market or expected to get launched during the study period. The analysis covers Prurigo Nodularis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Prurigo Nodularis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Prurigo Nodularis Therapies and Key Companies
*
Nalbuphine ER: Trevi Therapeutics
*
Nemolizumab: Galderma
*
Vixarelimab(KPL-716): Genentech
*
Povorcitinib(INCB-54707): Incyte Corporation
*
Ruxolitinib Cream: Incyte Corporation
*
INCB054707: Incyte Corporation
*
serlopitant: Vyne Therapeutics Inc.
*
CC-10004: Celgene Corporation
*
Pimecrolimus: Novartis
*
Abrocitinib: Pfizer
*
Dupilumab SAR231893: Regeneron Pharma
Discover more about therapies set to grab major Prurigo Nodularis market share @ Prurigo Nodularis Treatment Market [https://www.delveinsight.com/sample-request/prurigo-nodularis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Prurigo Nodularis Market Strengths
*
Novel drug formulations are unlocking the new market outlook and the potential to improve the QoL of patients suffering from the serious symptoms associated with chronic neurologically mediated conditions for which there are few, if any, treatment options.
*
Vixarelimab's dual mechanism offers potential pruritus relief and nodule improvement in prurigo nodularis.
Prurigo Nodularis Market Opportunities
*
Increasing population gives a lucrative opportunity to increase the awareness and innovation of therapeutics to drive the prurigo nodularis market.
*
Due to one approved drug in the market, there is a huge opportunity for the companies who are coming with novel emerging therapies.
Scope of the Prurigo Nodularis Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Prurigo Nodularis Companies: Trevi Therapeutics, Galderma, Genentech, Incyte Corporation, Vyne Therapeutics Inc., Celgene Corporation, Novartis, Pfizer, Regeneron Pharma, and others
*
Key Prurigo Nodularis Therapies: Nalbuphine ER, Nemolizumab, Vixarelimab(KPL-716), Povorcitinib(INCB-54707), Ruxolitinib Cream, INCB054707, serlopitant, CC-10004, Pimecrolimus, Abrocitinib, Dupilumab SAR231893, and others
*
Prurigo Nodularis Therapeutic Assessment: Prurigo Nodularis current marketed and Prurigo Nodularis emerging therapies
*
Prurigo Nodularis Market Dynamics: Prurigo Nodularis market drivers and Prurigo Nodularis market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Prurigo Nodularis Unmet Needs, KOL's views, Analyst's views, Prurigo Nodularis Market Access and Reimbursement
To know more about Prurigo Nodularis companies working in the treatment market, visit @ Prurigo Nodularis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/prurigo-nodularis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Prurigo Nodularis Market Report Introduction
2. Executive Summary for Prurigo Nodularis
3. SWOT analysis of Prurigo Nodularis
4. Prurigo Nodularis Patient Share (%) Overview at a Glance
5. Prurigo Nodularis Market Overview at a Glance
6. Prurigo Nodularis Disease Background and Overview
7. Prurigo Nodularis Epidemiology and Patient Population
8. Country-Specific Patient Population of Prurigo Nodularis
9. Prurigo Nodularis Current Treatment and Medical Practices
10. Prurigo Nodularis Unmet Needs
11. Prurigo Nodularis Emerging Therapies
12. Prurigo Nodularis Market Outlook
13. Country-Wise Prurigo Nodularis Market Analysis (2020-2034)
14. Prurigo Nodularis Market Access and Reimbursement of Therapies
15. Prurigo Nodularis Market Drivers
16. Prurigo Nodularis Market Barriers
17. Prurigo Nodularis Appendix
18. Prurigo Nodularis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=prurigo-nodularis-market-forecasted-to-surge-in-coming-years-20242034-analysis-by-delveinsight-celgene-crp-novartis-pfizer-galderma-genentech-incyte-crp-trevi-therapeutics-vyne-therap]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/blog/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prurigo Nodularis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Celgene Crp., Novartis, Pfizer, Galderma, Genentech, Incyte Crp., Trevi Therapeutics, Vyne Therap here
News-ID: 3764317 • Views: …
More Releases from ABNewswire
Storm Preparedness Plans Enhanced by Water Mitigation Company in Edina
Preventive strategies and expert guidance now stand at the forefront of property maintenance, with trusted local providers ensuring lasting solutions.
Rising Need for Proactive Protection
Seasonal storms across Minnesota have amplified the need for reliable property protection, and water mitigation has become a central focus for residents and businesses alike. Many homeowners are turning to search terms like water mitigation company near me [https://www.google.com/search?water+mitigation+company+near+me&kgmid=/g/11s2y26ttm] to secure timely help before emergencies escalate. Preventive…
Patient Comfort Prioritized by Orthodontist in Gainesville GA with Modernized Pr …
Patients now expect not only effective treatments but also a more positive and stress-free experience. As technology evolves, leading practices are modernizing their methods to meet these demands.
Advancing Orthodontic Care in Gainesville
The growing need for comprehensive dental solutions has brought increased attention to the role of an orthodontist Gainesville GA [https://www.google.com/search?orthodontist+Gainesville+GA&kgmid=/g/11tf41mhhd] in ensuring both comfort and long-term oral health. Patients now expect not only effective treatments but also a more…
Elite Remodels Las Vegas: Transforming Homes Into Dream Spaces With Unmatched Cr …
Elite Remodels Las Vegas, a leading name in high-quality home renovation and design, is redefining the remodeling experience for homeowners across the Las Vegas Valley. With over a decade of expertise, a client-first approach, and a passion for delivering spaces that reflect individuality and style, Elite Remodels continues to set the benchmark for excellence in home transformation.
Las Vegas, NV - Elite Remodels Las Vegas, a leading name in high-quality home…
"Nigerian Cowboy" - A Bold New Novel Blending African Roots with the Spirit of t …
What happens when a Nigerian boy dares to dream of becoming a cowboy? In his groundbreaking debut novel, Nigerian Cowboy , Dr. Emmanuel X. Okoro takes readers on a journey that fuses African identity, Western grit, and the timeless pursuit of belonging.
From a small Nigerian village to the sprawling ranches of Texas, Nigerian Cowboy follows Jacob Obi, a dreamer determined to prove that courage knows no borders. Through trials, rivalries,…
More Releases for Prurigo
Prurigo Nodularis Market Growth, Applications, Innovations and Business Outlook …
Introduction
Prurigo nodularis (PN) is a rare, chronic inflammatory skin disease characterized by intensely itchy nodules that severely impair quality of life. The exact cause remains unclear, but PN is linked to immune dysregulation, chronic pruritus pathways, and systemic diseases such as atopic dermatitis, diabetes, and liver disorders. For decades, management relied on corticosteroids, antihistamines, and immunosuppressants, with limited efficacy and safety concerns in long-term use.
The landscape has changed dramatically with…
Prurigo Nodularis Treatment Market Opportunities & Challenges, Novel Therapies T …
The Global Prurigo Nodularis Treatment Market reached USD 964.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 1.1 billion by 2031. The Global Prurigo Nodularis Treatment Market is exhibiting at a CAGR of 3.7% during the forecast period 2024-2031.
Prurigo Nodularis Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to…
Prurigo Nodularis Pipeline: Emerging Therapies Set to Reshape the Prurigo Nodula …
The treatment landscape of Prurigo Nodularis (PN), a chronic, intensely pruritic skin disorder, is undergoing a dynamic transformation, fueled by a growing pipeline of novel therapeutics from leading pharma and biotech companies. Notable players such as Menlo Therapeutics, Galderma R&D, and Kiniksa Pharmaceuticals are driving innovation with therapies targeting underlying immune dysregulation, including IL-31 and JAK/STAT pathways, central to PN pathogenesis. These emerging drugs aim to address the high unmet…
Prurigo Nodularis Treatment Market Current Status and Future Prospects till 2031
Prurigo Nodularis (PN) is a chronic dermatologic condition marked by intense itching and the development of nodules on the skin. The Prurigo Nodularis Treatment Market focuses on therapeutic interventions to alleviate symptoms and provide relief to patients suffering from this condition. Treatments include topical corticosteroids, immunosuppressants, and biologic therapies. The current market value of Prurigo Nodularis treatment is driven by the increasing awareness of PN and advancements in treatment options.…
Prurigo Nodularis Treatment Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Prurigo Nodularis Treatment Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.
Market Overview for Prurigo Nodularis Treatment Market
Prurigo Nodularis Treatment Market OverviewPrurigo nodularis (PN) is a chronic skin condition characterized by intensely itchy nodules or papules that can significantly impair quality of…
Prurigo nodularis Market: F: Information, Figures and Analytical Insights 2021-2 …
The Prurigo nodularis Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the…
